Biomerica (BMRA) Revenue (2010 - 2026)

Biomerica (BMRA) has 17 years of Revenue data on file, last reported at $987000.0 in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 11.8% year-over-year to $987000.0; the trailing twelve-month figure through Feb 2026 stood at $4.3 million (down 23.81% YoY), and the FY2025 full-year result was $5.3 million, down 1.92% from the prior year.
• Revenue fell to $987000.0 in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.7 million in Q1 2022 to a low of $749000.0 in Q2 2025.
• A 5-year average of $1.9 million and a median of $1.4 million in 2025 frame the typical range for Revenue.
• Across the five-year window, Revenue jumped 403.0% in 2022 and slumped 85.5% in 2023, its largest moves.
• Tracing BMRA's Revenue over 5 years: stood at $1.5 million in 2022, then grew by 5.74% to $1.6 million in 2023, then rose by 4.4% to $1.6 million in 2024, then slipped by 26.04% to $1.2 million in 2025, then slipped by 18.43% to $987000.0 in 2026.
• Business Quant data shows BMRA's Revenue at $987000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.